🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

NEW: @BATPlc’s R.J. Reynolds Vapor Co. failed to shed a North Carolina jury’s $95.2 million verdict finding its Vuse Alto e-cigarette infringes three Altria vape-pod patents, as an appeals court rejected Reynolds’ challenge. news.bloomberglaw.com/ip-law/reynold…

If you missed our breaker on this doozy of a verdict, here's your chance to catch up: Nippon Shinyaku Co. must pay Sarepta Therapeutics and the @UWAnews $115.2 million for patent infringement by its Viltepso drug, a federal jury found Friday. news.bloomberglaw.com/ip-law/nippon-…

Five patents for @TevaPharm's ProAir HFA asthma inhaler don’t cover the drug's active ingredient & must be delisted from U.S. FDA’s registry of approved drugs, an appeals court ruled. Affirmed Amneal Pharmaceuticals's June victory in the underlying case. news.bloomberglaw.com/ip-law/teva-mu…

YESTERDAY: Microsoft’s virtual assistants and AI services (Cortana, Copilot, Azure AI, and Azure OpenAI) infringe nine patents for technology developed by voice software pioneer VoiceBox Technologies, @DialectLLC said in a federal lawsuit. news.bloomberglaw.com/ip-law/microso…

A federal judge in Delaware upheld 10x Genomics’ $31 million verdict win against Bruker's NanoString Technologies Inc. and blocked sales of its GeoMx spatial-imaging products, but declined to increase the damages. news.bloomberglaw.com/ip-law/10xs-31…

.Invitae urged a fed. judge to reject Natera’ bid for supplemental damages & an ongoing royalty, after a jury awarded $NTRA $19.4M for infringing patents for personalized cancer-monitoring products. $NVTA, meanwhile, sold most assets to @LabCorp. news.bloomberglaw.com/ip-law/invitae…

Five @PurduePharma patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid, a Federal Circuit panel said. It affirmed a Delaware district judge's voiding of patents in suit over copy by Intas' Accord unit. news.bloomberglaw.com/ip-law/purdue-…

NEW: @Pfizer asked a federal court in Delaware to block copies of blockbuster arthritis drug Xeljanz proposed by Alkem Laboratories Ltd. that it said infringe a patent expiring this year. It's the only Orange Book-listed patent for the 5- & 10-mg tablet formulations. news.bloomberglaw.com/ip-law/pfizer-…

Innovative Health Sciences LLC built its Insignis syringe infusion system using insider knowledge from a former @KoruMedical executive, infringing $KRMD patent for safely controlling the flow rate of therapeutic fluids to patients, a federal lawsuit said. news.bloomberglaw.com/ip-law/koru-su…

NEW: Acuitas Therapeutics asked a federal court to find the Covid-19 vaccine Comirnaty doesn’t infringe five patents at issue in GSK’s separate lawsuit seeking a share of the billions of dollars Acuitas’ partners @Pfizer and BioNTech SE have made from it. news.bloomberglaw.com/ip-law/acuitas…

NEW: Boston Dynamics settled 2 suits alleging WA Ghost Robotics copied patented tech to build its robotic dogs. BD sued Philly's GR in 11/2022 & 2/2024 alleging its Vision 60 & Spirit 40 products infringe patents. Jury trial in 1st case had been set for Feb. news.bloomberglaw.com/ip-law/boston-…

NEW: @BlueAllele stole @IntelliaTx’s pioneering gene-editing tech for inserting healthy DNA into genes to enhance genetic-disease treatments and falsely claimed inventorship of patents central to treating genetic disorders, $NTLA said in a court filing. news.bloomberglaw.com/ip-law/blueall…

.EchoStar's @Dish unit asked the US Supreme Court to review whether courts can require attorneys to pay legal fees in exceptionally frivolous patent cases, part of a dispute over DVR technology. news.bloomberglaw.com/ip-law/dish-as…

NEW: Novartis asked two federal courts to block MSN Laboratories Pvt. Ltd.’ generic Entresto after a key patent’s revival and to require the U.S. FDA to enforce pediatric-exclusivity rights for $NOVN's blockbuster heart drug. news.bloomberglaw.com/ip-law/novarti…

NEW: @Neurocrine said in a federal lawsuit that Spruce Biosciences is threatening patent litigation over $NBIX's new rare disease drug Crenessity due to a “desperate need for cash." Neurocrine seeks to void $SPRB's “impermissibly overbroad” patent. news.bloomberglaw.com/ip-law/neurocr…

From the SIGN HERE; NO, REALLY Dept.🖋️: Astellas Pharma US can’t enforce a patent-infringement settlement with MSN Laboratories Pvt. Ltd. over a generic version of the overactive-bladder drug Myrbetriq because the deal was never signed, a federal judge ruled. news.bloomberglaw.com/ip-law/astella…

Thanks for the shout-out, Chris Morten! And thanks to Chris Morten (of Columbia Law School), PrEP4All, Treatment Action Group (TAG) & Reshma Ramachandran, each of whom shared time and energy discussing the basis for their perspectives on HHS.gov's settlement last week w/ Gilead Sciences on PrEP drugs.

Import 300K bottles of generic Entresto in August & 2,200 kg of the blockbuster heart-failure drug’s active ingredient in December, and what do you get? A Novartis suit seeking damages for MSN Laboratories Pvt. Ltd.' alleged infringement of a recently revived patent. news.bloomberglaw.com/ip-law/novarti…